SciELO - Scientific Electronic Library Online

SciELO - Scientific Electronic Library Online

Referencias del artículo

DE LUIS, D. A. et al. Relación del polimorfismo -55CT del gen UCP3 con la pérdida de peso y los cambios metabólicos tras una dieta hipocalórica rica en ácidos grasos poliinsaturados en pacientes obesos. Nutr. Hosp. [online]. 2012, vol.27, n.4, pp.190-1195. ISSN 0212-1611.  http://dx.doi.org/10.3305/nh.2012.27.4.5787.

    1. Tuomilehto J, Lindstrom J, Eriksson JG. Finnish Diabetes Prevention Study Group: prevention of type 2 diabetes mellitus changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 2001; 344: 1343-1350. [ Links ]

    2. Matsuzawa Y. Adipocytokines: Emerging therapeutic targets. Current Atherosclerosis Reports 2005; 7: 58-62. [ Links ]

    3. Vidal Puig A, Solanes G, Grujic D, Flier J, Lowell BB. UCP3: an uncoupling protein homologue expressed preferentially and abundantly in skeletal muscle and brown adipose tissue. Biochem Biophys Res Commun 1997; 235: 79-82. [ Links ]

    4. Saltzman E, Roberts SB. The role of energy expenditure in energy regulation: findings from a decade research. Nutr Rev 1995; 53: 209-220. [ Links ]

    5. Bouchard C, Perusse L, Chagnon YC, Warden C, Ricquier D. Linkage between markers in the vicinity of uncopuling protein 2 gene and resisting metabolic rate in humans. Hum Mol Gent 1997; 6: 1887-1889. [ Links ]

    6. Clapham J, Arch J, Chapman H. Mice overexpressing human uncoupling protein 3 in skeletal muscle are hyperphagic lean. Nature 2000; 406: 415-418. [ Links ]

    7. Samec S, Seydoux J, Dullo A. Role of UCP homologues in skeletal muscle and free fatty acids in obesity. Lancet 1998; 351: 1933-1934. [ Links ]

    8. Otabe S, Clement K, Dina C. A genetic variation in the 5'flanking region of the UCP3 is associated with body mass index in humans in interaction with physical activity. Diabetologia 2000; 43: 245-249. [ Links ]

    9. Meirhaeghe A, Amoyel P, Helbecque N. An uncoupling protein 3 gene polymorphism associated with a lower risk of developing type 2 diabetes and with atherogenic lipid profile in a French cohort. Diabetologia 2000; 43: 1424-1428. [ Links ]

    10. De Luis DA, Aller R, Izaola O, Sagrado M, Conde R. Modulation of adipocytokines response and weight loss secondary to a hypocaloric diet in obese patients by -55ct polymorphism of UCP3 gene. Horm Metab Res 2008; 40: 214-218. [ Links ]

    11. De Luis DA, Aller R, Izaola O, Gonzalez M, Conde R. Modulation of adipocytokines response and weight loss secondary to a hypocaloric diet in obese patients by -55ct polymorphism of UCP3 gene. Horm Metab Res 2009; 41: 62-66. [ Links ]

    12. Matsuzawa Y. Adipocytokines: Emerging therapeutic targets. Current Atherosclerosis Reports 2005; 7: 58-62. [ Links ]

    13. Okasaki T, Himeno E, Nanri H, Ogata H, Ikeda M. Efectsof mild aerobic exercise and a mild hypocaloric diet on plasma leptin in sedentary women. Clin Exp Pharmacol 1999; 26: 415-420. [ Links ]

    14. Xenachis C, Samojlik E, Raghuwanshi MP, Kirschner MA. Leptin, insulin and TNF-alpha in weight loss. J Endocrinol Invest 2001; 24: 865-870. [ Links ]

    15. Mathews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher Df. Homesotasis model assessment: insulin resistance and beta cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412-414. [ Links ]

    16. Duart MJ, Arroyo CO, Moreno JL. Validation of a insulin model for the reactions in RIA. Clin Chem Lab Med 2002; 40: 1161-1167. [ Links ]

    17. Pfutzner A, Langefeld M, Kunt T, Lobig M. Evaluation of human resistin assays with serum from patients with type 2 diabetes and different degrees of insulin resistance. Clin Lab 2003; 49: 571-576. [ Links ]

    18. Meier U, Gressner M. Endocrine regulation of energy metabolis: review of pathobiochemical and clinical chemical aspects of leptin, Ghrelin, adiponectin, and resistin. Clinical Chemistry 2004;50:1511-1525. [ Links ]

    19. Suominen P. Evaluation of an enzyme immunometric assay to measure serum adiponectin concentrations. Clin Chem 2004; 50:219-221. [ Links ]

    20. Lubrano V, Cocci F, Battaglia D, Papa A. Usefulness of highsensitivity IL6 measurment for clinical characterization of patients with coronary artery disease. J Clin Lab Anal 2005; 19:110-114. [ Links ]

    21. Khan SS, Smith MS, reda D, Suffredini AF, Mc Coy JP. Multiplex bead array assays for detection of soluble cytokines: comparisons of sensitivity and quantitative values among kits from multiple manufactures. Cytometry B Clin Cytom 2004; 61: 35-39. [ Links ]

    22. Lukaski H, Johson PE. Assessment of fatfree mass using bioelectrical impedance measurements of the human body. Am J Clin Nutr 1985; 41 (4): 810-7. [ Links ]

    23. Mataix J, Mañas M. Tablas de composición de alimentos españoles. Ed: University of Granada, 2003. [ Links ]

    24. Hesselink MKC, Mensink M, Schrauwen. Human uncoupling protein-3 and obesity. Obesity Research 2003; 11: 1429-1440. [ Links ]

    25. Millet L, Vidal H, Andreelli F. Increased uncoupling protein 2 and 3 mRNA expression during fasting in obese and lean humans. J Clin Invest 1997; 100: 2665-2670. [ Links ]

    26. Dalgaard LT, Sorensen TIA, Drivshom T, Borch Johnsen K, Andersen T, Hansen T. A prevalent polymorphism in the promoter of the UCP3 gene and its relationship to body mass index and long term body weight change in the Danish population. J Clin Endoc Metab 2001; 86: 1398-1402. [ Links ]

    27. Alonso A, Marti A, Corbalán MS, Martínez González MA, Forga L, Martínez JA. Association of UCP3 gene -55CT polymorphism and obesity in a Spanish population. Ann Nutr Metab 2005; 49: 183-188. [ Links ]

    28. Liu YJ, Liu PY, Long J, Lu Y, Elze L, Recker RR, Deng HW . Linkage and association analyses of the UCP3 gene with obesity phenotypes in Caucasian families. Physiol Genomics 2005; 22: 197-203. [ Links ]

    29. De Luis DA, Pacheco D, Aller R, Goznalez M, Izaola O, Terroba MC, Cuellar L, Conde R, Martin T, Perez Castrillon JL. Influence of -55CT polymorphism of UCP3 gene on surgical results of biliopancreatic diversion. Obes Surg 2010; 20: 895-9. [ Links ]

    30. Cha MH, Shin D, Soo Kim K, Hee Lee B, Yoon Y. The effects od uncopupling protein 3 haplotypes on obesity phenotypes and very lowenergy dietinduced changes among overweight Korean female subjects. Metabolism Clin and Experimental 2006; 55: 578-586. [ Links ]

    31. Yoon Y, Lae Park B, Cha M, Soo Kim K, Sun Cheong H, Hyun Choi Y. Effects of genetic polymorphisms of UCP2 and UCP3 on very low calorie dietinduced body fat reduction in Korean female subjects. Biochemical and Biophysical Research Communication 2007;359:451-456. [ Links ]

    32. De Luis DA, Aller R, Izaola O, González Sagrado M, Conde R, De La Fuente B, Valle HFO. Frecuencia alélica Del polimorfismo G308A Del factor de necrosis tumoral alfa y elación con los factores de riesgo cardiovascular y adipocitoquinas em pacientes obesos. Nutrición Hospitalaria 2011; 26: 711-715. [ Links ]

    33. De Luis DA, González Sagrado M, Conde R, Aller R, Izaola O, Castro MJ. Adipocitoquinas circulantes en obesos mórbidos, relación con factores de riesgo cardiovascular y parámetros antropométricos. Nutr Hosp 2011; 26: 91-96. [ Links ]

    34. De Luis DA, Aller R, Izaola O, González Sagrado M, Conde R. Relation of C358A polymorphism of the endocannabinoid degrading enzyme fatty acid amide hydrolase with obesity and insulin resistance. Nutr Hosp 2010; 25: 993-998. [ Links ]

    35. De Luis DA, González Sagrado M, Aller R, Conde R, Izaola O, De la Fuente B, Primo D. Roles of G13559A polymorphism of the endocannabinoid receptor gene (CNR1) on weight loss and adipocytokines after a hypocaloric diet. Nutr Hosp 2011; 26: 317-323. [ Links ]